<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-74387</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants</dc:title>
<dc:description xml:lang="en">Acute tumour lysis syndrome (TLS) is a catastrophic complication of the treatment of certain neoplastic disorders. It most commonly occurs in association with hematologic malignancies and appears a few hours to a few days after initiation of specific chemotherapy, as the result from the release of intracellular components into the bloodstream due to abrupt malignant cell death. Acute spontaneous TLS is rare, and it has been described in leukemia and lymphoma and in some patients with solid tumors prior to institution of therapy. The syndrome is characterized by hyperuricemia, hyperphosphatemia, hypocalcemia, hyperkalemia, and acute oliguric or anuric renal failure due to uric acid precipitation within the tubules (acute uric acid nephropathy) and to calcium phosphate deposition in the renal parenchyma and vessels. We report a case of acute spontaneous TLS in a patient with Crohn's disease treated with immunosuppressive drugs, who developed a plasmocytoma, in which serum uric acid concentration attained exceptionally high levels (44 mg/dL). The patient underwent acute oliguric renal failure, which required treatment with hyperhydration, urine alkalinization, urate oxidase and hemodialysis, with a fatal evolution. In conclusion, the present case report has several peculiarities: that of being one of the rare examples of spontaneous TLS, that of showing an exceptionally severe hyperuricemia, probably the highest ever reported in the literature, and that of the possible increased risk of tumours in patients with Crohn's disease taking inmunosuppressives and/or TNF antagonists(AU)</dc:description>
<dc:creator>Manceñido Marcos, N</dc:creator>
<dc:creator>Froilán Torres, C</dc:creator>
<dc:creator>Pajares Villarroya, R</dc:creator>
<dc:creator>Martín Arranz, M. D</dc:creator>
<dc:creator>Peces, R</dc:creator>
<dc:creator>Benito López, D</dc:creator>
<dc:creator>Castro Carbajo, P</dc:creator>
<dc:creator>Plaza Santos, R</dc:creator>
<dc:creator>Gómez Senent, S</dc:creator>
<dc:creator>Martín Arranz, E</dc:creator>
<dc:creator>Adán Merino, L</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El síndrome de lisis tumoral (SLT) es una complicación catastrófica del tratamiento de ciertas enfermedades neoplásicas. Si bien es más frecuente en pacientes con neoplasias hematológicas malignas tras el inicio de la quimioterapia, puede presentarse excepcionalmente, tras la necrosis espontánea de algunos tumores, en ausencia de tratamiento citostático. Clínicamente cursa con hiperuricemia, hiperfosfatemia, hipocalcemia, hiperpotasemia y fallo renal agudo. Presentamos el caso de un paciente con enfermedad de Crohn en tratamiento inmunospresor, que desarrolló un síndrome de lisis tumoral espontáneo como debut de un plasmocitoma. Al ingreso, se objetivó un fracaso renal oligoanúrico que, a pesar de tratamiento precoz con hiperhidratación, alcalinización de la orina, urato-oxidasa y hemodiálisis, tuvo un desenlace fatal en 72 horas. Este caso reviste un interés particular por lo excepcional de la naturaleza "espontánea" del síndrome de lisis tumoral en ausencia de quimioterapia, por presentarse con una hiperuricemia extrema, probablemente la más alta de las recogidas en la literatura, y por la controversia actual de la terapia con inmunosupresores y/o biológicos en la enfermedad inflamatoria intestinal y su relación con el desarrollo de determinados tumores(AU)</dc:description>
<dc:source>Rev Esp Enferm Dig;101(4): 288-294, abr. 2009.</dc:source>
<dc:identifier>ibc-74387</dc:identifier>
<dc:title xml:lang="es">Síndrome de lisis tumoral &#147;espontáneo&#148; en paciente con enfermedad de Crohn tratado con inmunosupresores</dc:title>
<dc:subject>^d53982^s22016</dc:subject>
<dc:subject>^d7344^s22073</dc:subject>
<dc:subject>^d10378^s22016</dc:subject>
<dc:subject>^d23973^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d12888^s22016</dc:subject>
<dc:subject>^d23973^s22016</dc:subject>
<dc:subject>^d53982^s22012</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200904</dc:date>
</metadata>
</record>
</ibecs-document>
